We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTXB
376
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $10.5M | 0.02% |
244,152
-20,519
| -8% | -$899K |
|
377
Harley-Davidson
HOG
$2.71B
| $10.4M | 0.02% |
242,285
-3,842
| -2% | -$184K |
|
378
Sun Communities
SUI
$14.7B
| $10.4M | 0.02% |
+113,460
| New | +$10M |
|
|
AXDX
379
DELISTED
Accelerate Diagnostics
AXDX
| $10.4M | 0.02% |
45,348
-17,811
| -28% | -$4.68M |
|
380
Liberty Latin America Class C
LILAK
$1.64B
| $10.3M | 0.02% |
+632,695
| New | +$11.6M |
|
381
US Bancorp
USB
$99.6B
| $10.3M | 0.02% |
203,679
-4,126
| -2% | -$226K |
|
|
TPIC
382
DELISTED
TPI Composites
TPIC
| $10.3M | 0.02% |
457,873
-16,356
| -3% | -$336K |
|
383
Mid-America Apartment Communities
MAA
$15.7B
| $10.3M | 0.02% |
112,544
-21,779
| -16% | -$1.97M |
|
384
Cabot Corp
CBT
$4.52B
| $10.2M | 0.02% |
183,945
-10,537
| -5% | -$665K |
|
|
HES
385
DELISTED
Hess
HES
| $10.1M | 0.02% |
200,482
-30,293
| -13% | -$1.48M |
|
386
Celanese
CE
$4.82B
| $10.1M | 0.02% |
+101,256
| New | +$10.7M |
|
387
Newell Brands
NWL
$2.56B
| $10.1M | 0.02% |
398,157
-22,242
| -5% | -$629K |
|
388
Vail Resorts
MTN
$5.3B
| $10.1M | 0.02% |
45,664
-817
| -2% | -$179K |
|
389
PG&E
PCG
$38.5B
| $9.97M | 0.02% |
227,058
-2,591
| -1% | -$110K |
|
390
Helen of Troy
HELE
$693M
| $9.96M | 0.02% |
114,526
+1,160
| +1% | +$106K |
|
|
QEP
391
DELISTED
QEP RESOURCES, INC.
QEP
| $9.93M | 0.02% |
1,014,643
+22,895
| +2% | +$216K |
|
392
Nomad Foods
NOMD
$1.68B
| $9.93M | 0.02% |
630,685
+14,412
| +2% | +$238K |
|
393
Sally Beauty Holdings
SBH
$1.58B
| $9.77M | 0.02% |
593,589
+6,013
| +1% | +$103K |
|
|
VRNT
394
DELISTED
Verint Systems
VRNT
| $9.71M | 0.02% |
447,258
-25,589
| -5% | -$527K |
|
395
Helios Technologies
HLIO
$2.76B
| $9.7M | 0.02% |
181,046
+22,049
| +14% | +$1.3M |
|
|
AQUA
396
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $9.69M | 0.02% |
455,080
-251,691
| -36% | -$5.79M |
|
|
ACC
397
DELISTED
American Campus Communities, Inc.
ACC
| $9.69M | 0.02% |
250,764
-16,750
| -6% | -$631K |
|
398
Ares Capital
ARCC
$14.4B
| $9.67M | 0.02% |
609,263
-120,544
| -17% | -$1.91M |
|
399
Semtech
SMTC
$13B
| $9.66M | 0.02% |
247,477
-513,593
| -67% | -$18.5M |
|
400
Floor & Decor
FND
$6.68B
| $9.65M | 0.02% |
185,132
-3,308
| -2% | -$156K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.